Please join Sidley for the Bay Area Lifesciences Roundtable, an afternoon of provocative discussions addressing cutting-edge trends and hot topics.
- Getting Funded: Prioritizing your pipeline and exploring funding alternatives and strategic opportunities to advance your initiatives.
- Getting Approved: Creative approaches to ensuring regulatory success in new product development.
- Getting Paid: Strategies to address emerging issues in drug pricing and reimbursement at all phases of drug development, marketing, and business development activities.
Megan Duplanty, Vice President, Deputy General Counsel, BioMarin Pharmaceutical Inc.
Rekha Hemrajani, Member, Board of Directors, BioAge Labs
Maryam Khotani, Associate General Counsel, Practice Group Leader, Genentech
Michael Listgarten, General Counsel, RAPT Therapeutics
Grace McMahon, Head of Transactions, Merck
Erin Quirk, M.D., President, Terns Pharmaceuticals
Rekha Ramesh, Vice President, Head of Global Policy, Government Affairs and Policy, Gilead Sciences
Joel Silver, JD, RAC, Lead Regulatory Counsel at Gilead Sciences
Frank Tang, Executive Director, Morgan Stanley
Lisa Taylor Ash, General Counsel, Shape Therapeutics
Additional panel information to be announced.
- 1:00 p.m. – Registration
- 1:30 p.m. – Program
- 4:30 p.m. – Cocktail reception
Who Should Attend
Executives, Investors, General Counsel and Company Counsel
CLE credit for this program is pending.
For questions, please contact GlobalLifeSci@sidley.com.